News & AnalysisDCVC Bio targets $275m for sophomore fundDCVC Bio is seeking to raise $275 million for its second fund, according to an SEC filing.ByIris Dorbian29 May 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingFundraisingBriefs